Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome
Authors:
- Ryong KimRKRyong Kim
- Lars KrügerLKLars Krüger
- Krystyna H. ChrzanowskaKCKrystyna H. Chrzanowska
- Eva SeemanovaESEva Seemanova
- Martin DigweedMDMartin Digweed
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaBlood, 2009
- Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense‐mediated mRNA decayGenes, Chromosomes and Cancer, 2008
- The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndromeOncogene, 2007
- Overexpression of NBS1 Contributes to Transformation through the Activation of Phosphatidylinositol 3-Kinase/AktJournal of Biological Chemistry, 2005
- Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse modelsNature Cell Biology, 2005
- An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viabilityHuman Molecular Genetics, 2004
- Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instabilityOncogene, 2004
- Altered expression of DNA double‐strand break detection and repair proteins in breast carcinomasHistopathology, 2003
- Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implicationsHuman Mutation, 2001
- beta 0 thalassemia, a nonsense mutation in man.Proceedings of the National Academy of Sciences, 1979